← Back to Search

Noninvasive Brain Stimulation

Active transcranial magnetic stimulation for Post-Traumatic Stress Disorder

Waitlist Available
Research Sponsored by Laval University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
18-60 years old
Be between 18 and 65 years old
Screening 3 weeks
Treatment Varies
Follow Up 2 months
Awards & highlights


The purpose of this trial is to study the effect of noninvasive brain stimulation in adults with post-traumatic stress disorder.

Eligible Conditions
  • Post-Traumatic Stress Disorder

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below


Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~2 months
This trial's timeline: 3 weeks for screening, Varies for treatment, and 2 months for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Severity of symptoms on the following clinical scale: PTSD symptoms as assessed by the Modified PTSD Symptom Scale (MPSS-SR)
Secondary outcome measures
Mental Depression

Trial Design

2Treatment groups
Active Control
Placebo Group
Group I: Active transcranial magnetic stimulationActive Control1 Intervention
Active transcranial magnetic stimulation will induce real pulses using the transcranial magnetic stimulation device.
Group II: Sham transcranial magnetic stimulationPlacebo Group1 Intervention
Sham transcranial magnetic stimulation will not induce any pulses using the same transcranial magnetic stimulation device but by also adding a sham block device.

Find a Location

Who is running the clinical trial?

Laval UniversityLead Sponsor
422 Previous Clinical Trials
172,818 Total Patients Enrolled
~3 spots leftby Jul 2025